R-Tech Ueno: Protocol Amendment Of A Phase I Clinical Study Of RK-023 For The Treatment Of Hypotrichosis Of The Eyelashes
R-Tech Ueno (JASDAQ:4573) is pleased to announce protocol amendment of a Phase I Clinical Study of RK-023, a new compound being developed for the treatment of hypotrichosis of the eyelashes (Note). The details are given below...